A bill to provide incentives to increase research by commercial, for-profit entities to develop vaccines, microbicides, diagnostic technologies, and other drugs to prevent and treat illnesses associated with a biological or chemical weapons attack.
Makes entities engaged in countermeasure research eligible for tax incentives, participation in the Bioterrorism Countermeasures Purchase Fund, and patent extension and liability protections, as specified.
Sets forth the tax incentives which include limited partnerships, total exclusion for gain from stock, and special countermeasure research credits.
Provides for the establishment of the Bioterrorism Countermeasures Purchase Fund to purchase countermeasures. Provides for such countermeasures' distribution by the Director of the Centers for Disease Control and Prevention.
Provides for the election of extended patent protection for eligible countermeasures, as specified.
Amends the Public Health Service Act to indemnify and defend persons and entities engaged in the research, production, or use of countermeasures.
Authorizes the Director of the National Institutes of Health to award grants and contracts for the construction of certain biosafety research facilities.
Authorizes the Director to award partnership challenge grants to promote joint ventures between the public and private sectors for the development of countermeasures and research tools.
Introduced in Senate
Sponsor introductory remarks on measure. (CR S12376-12385)
Read twice and referred to the Committee on Finance.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line